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We present a description of a rare but dangerous case of fungal meningitis caused by
Aspergillus terreus in an immunocompetent patient with a history of sinus disease.
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BACKGROUND
Central nervous system (CNS) infection is one of themost disabling and deadly diseases worldwide.
According to theWorld Health Organization, there were about 700,000 cases of meningitis in 2004,
with approximately 340,000 related deaths (Mathers et al., 2004). CNS infectious pathogens include,
infection with bacteria, viruses, fungi, and parasites. Fungal infection is generally opportunistic and
has gradually increased in recent years, mainly due to the increase in acquired immunodeficiency
syndrome (AIDS), transplant surgery and drug resistance to antifungal medication. Cryptococcus
neoformans infection is still the most common CNS fungal infection, whereas Aspergillus and
Mucor are relatively uncommon causes of CNS infection (Qi, 2014). Aspergillosis CNS fungal
infectionmay present with various features depending on the pathogenicity of a specific pathogenic
species and the status of the host’s immune response (Rallis et al., 2014). The most common
primary sites of aspergillosis are lungs, paranasal sinuses, and ear canal (Baddley et al., 2003).
Aspergillosis of the paranasal sinuses is infrequent and usually involves the species Aspergillus
fumigatus orAspergillus flavus. The maxillary sinus is the most commonly affected sinus (Akhaddar
et al., 2008). Fungal rhinosinusitis (FRS) is divided into invasive and noninvasive diseases based on
histopathological evidence of tissue invasion by fungi. Invasive FRS is classified as acute, chronic,
or granulomatous. The non-invasive forms of fungal sinusitis are allergic FRS and the fungus
ball (fungal mycetoma) (Chakrabarti et al., 2009). Invasion of the CNS can occur through direct
extension from the paranasal sinuses, hematogenous dissemination though pulmonary/cutaneous
sources (Walsh et al., 2008) or by Iatrogenic inoculation of Aspergillus through spinal anesthesia,
neurosurgery, or epidural steroid injections (Antinori et al., 2013). CNS aspergillus infections
are mainly caused by A. fumigatus, A. flavus and rarely by Aspergillus terreus, Aspergillus oryzae,
Aspergillus granulosus, or Aspergillus candidus (Antinori et al., 2013). Although A. terreus is an
unusual cause of CNS invasion, its natural resistance to Amphotericin B is linked to a higher
mortality rate (Schwartz et al., 2007).
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CASE REPORT
Sixteen-year-old male patient from Burkina Faso presented to
emergency department of Al-Noor Specialist Hospital, which is
a Joint Commission International (JCI) accredited, tertiary care
hospital in the Holy city of Makkah, Saudi Arabia. The patient
presented with a history of fever; and recurrent convulsions,
followed by a decreased level of consciousness.
A week before the presentation the patient had nasal
polypectomy and sinus surgery in a private hospital. Two days
post-surgery the patient developed headache with high-grade
fever that did not respond to antibiotics. Headache became
progressively worse and the patient started experiencing episodes
of fits and loss of consciousness.
Assessment of vital signs on presentation revealed a
temperature of 37◦C, pulse of 112 beats per minute, and blood
pressure of 121/97mmHg. The physical examination revealed no
meningeal signs, pupils were normal and reactive, and there was
normal muscles tone. Glasgow Coma Scale was 6 (E1 M4V1),
so the patient was intubated and mechanical ventilation was
initiated.
Laboratory testing revealed a leukocyte count of 10,380 cells
per cubic millimeter, with 76.5% polymorphonuclear cells. ESR
was 42mm/h and CRP 7.97mg/dl. The comprehensive metabolic
panel; including liver-function tests, was within normal limits
(Table 1). Analysis of the cerebrospinal fluid revealed an elevated
protein level of 120mg/dl (reference range, 15–45), low glucose
concentration of 38 mg/dl (reference range of 40–70mg/dl).
Gram stain of CSF showed no bacteria, but white blood cells
were increased at 4200 white cells/µl; 90% polymorphonuclear
cells.
Computed tomography (CT) of the head showed dilatation of
supra and infratentorial ventricular system with hydrocephalic
changes. CT scan also suggested possible fungal sinusitis of
ethmoid, sphenoid, and maxillary sinuses. Other findings were
not remarkable and showed normal attenuation of cerebral
cortex and white matter, no intra or extra-axial hemorrhage
and normal posterior fossa structures (Figure 1). CT of the
chest showed left lower lobe consolidation with right upper
lobe linear atelectasis and mild ground glass density patches.
Mediastinal vascular structures were normal with no lymph node
enlargement, no pleural effusion, and normal chest wall.
The patient was started on intravenous vancomycin,
ceftriaxone, acyclovir, metronidazole, clindamycin, and
glucocorticoids.
TABLE 1 | Patient’s parameters during admission days.
Parameter 1 2 3 4 5 6 7
WBC’S (103/ul) 10.38 11.10 11.18 6.52 6.76 12.13 9.12
Hb (g/dl) 10.3 10.8 11.4 9.6 8.4 9.5 11.3
Urea (mg/dl) 27 27 39 106 145 153 167
Creatinine (mg/dl) 0.99 0.99 1.6 6.1 7.7 7.96 7.8
Blood glucose (mg/dl) 100 102 233 477 547 243 –
ALT(IU/l) 20 21 22 624 455 584 –
AST (IU/l) 26 27 49 1127 363 571 –
Routine bacterial cultures of the blood and cerebrospinal
fluid were negative, and microscopic examination of CSF
revealed acute inflammatory cells (neutrophil leucocytes) and few
admixed histocytes with conclusion of pyogenic meningitis.
On hospital day 3 the patient had signs of brain stem death
in the form of dilated fixed unreactive pupils, loss of corneal
and conjunctival reflexes and loss of gag reflexes. Brain death
was confirmed twice clinically by neurology department with an
interval of 24 h. Electroencephalography (EEG) was advised as
proof of brain stem death by electrophysiological studies.
On hospital day 4, the patient showed abrupt elevation of
blood glucose, urea, creatinine, and liver enzymes. EEG was
done using brain death standard technique for 30min and
revealed severe cerebral dysfunction. Patient was continued on
mechanical ventilation, but his blood pressure started to decrease.
The patient immediately received Alpha/Beta agonists in an
attempt to maintain his blood pressure at acceptable levels.
On hospital day 5, the microbiology laboratory reported a
filamentous fungus growth in the CSF specimen, which was
initially negative for bacteria. This positive CSF specimen was
collected on the first day of admission. The filamentous fungus
was later identified as Aspergillus species and the culture was
sent to a reference mycology laboratory for species identification.
Liposomal Amphotericin B and voriconazole were started on the
same day, but patient continued to deteriorate. The patient died
on hospital day 7 due to sudden cardiac arrest associated with
severe meningioencephalitis, renal impairment, and septic shock.
Isolation and Identification of Aspergillus
terreus
The CSF specimen was cultured in BACTEC FX blood culture
bottles and incubated using BACTEC FX system. Three days
after initial incubation, a positive culture signal was noted and
fungal ball was noted inside the culture bottle. The fungal ball
was directly inoculated onto blood, chocolate and Sabouraud’s
dextrose agar plates and incubated at 30◦C. Filamentous fungal
growth was obtained within 48 h and identification attempts were
made by means of macroscopic and microscopic examination
of the culture. Parallel CSF culture was performed according to
standard procedure and all results were negative.
The CSF filamentous fungus isolate was identified as
Aspergillus species by microscopic examination showing
characteristic Aspergillus fruiting heads. For species
determination Sabouraud’s dextrose agar plate was sent
to the Microbiology Research Laboratory, Department of
Microbiology, College of Medicine, Umm Al-Qura University.
Fungal Its-Based Identification Protocol
Washed fungal mycelium was used to isolate genomic DNA. A
library for ITS metagenomics DNA sequencing was prepared
using the Illumina Metagenomics Protocol and sequenced in
Illumina MiSeq using version-2 500 cycles Nano kit. Species
identification was determined using the Pairwise Sequence
Alignment tool, (ISHAM ITS database http://its.mycologylab.
org/). Sequence similarity equal to or greater than 97% was used
as cutoff for species identification. Alignment of assembled ITS
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FIGURE 1 | Imaging studies. Computed tomographic (CT) images of the head without administration of contrast, showing ethmoidal, sphenoid, and maxillary
sinuses occupied by hyperdense soft tissue suggesting fungal sinusitis (bilateral sinupolyposis).
sequences showed high degree of similarity (above 99.7%) to A.
terreus ITS reference sequences.
DISCUSSION
Aspergillus is a ubiquitous fungus in soil, water, decaying
vegetation and organic debris, and was recognized to be
pathogenic in humans as early as 1847. Abundant spore
formation and septate dichotomously branching hyphae
characterize the genus Aspergillus. Desiccation-resistant
Aspergillus spores can be easily dispersed by air currents.
Humans inhale hundreds of spores daily, which are usually
handled by alveolar macrophages and neutrophils. There are
more than 350 species of Aspergillus; however, only a few are
pathogenic in humans. The most common pathogenic species
are A. fumigatus and A. flavus, but many other species have
been reported to cause infection in humans. Microscopic
identification of Aspergillus is easy for some of the common
species, but for many species, it might be difficult and need
special expertise (Baddley et al., 2003).
The most common primary sites of aspergillosis are lungs,
paranasal sinuses, and ear canal (Baddley et al., 2003). Sinusitis
occurs in both healthy and immunocompromised patients.
Healthy patients can present with signs and symptoms of chronic
sinusitis or a mass (aspergilloma) in the maxillary or ethmoid
sinuses. Immunocompromised patients present with invasive
disease characterized by bony destruction with extension to
contiguous sites such as the orbit or CNS (William Schwartz,
2012). FRS is often characterized as invasive or noninvasive
diseases based on histopathological evidence of tissue invasion by
fungi. Invasive diseases include (1) acute invasive (fulminant), (2)
granulomatous invasive, and (3) chronic invasive. Noninvasive
diseases include (1) saprophytic fungal infestation, (2) fungal
ball, and (3) fungus related eosinophilia that includes allergic
FRS (Chakrabarti et al., 2009). Although allergic FRS has a
hypersensitivity etiology, a few reports document fungal invasion
(Thakar et al., 2004).
Invasion of the CNS can occur through direct extension
from the paranasal sinuses by hematogenous dissemination
though a pulmonary or cutaneous source (Walsh et al., 2008),
or by iatrogenic inoculation of Aspergillus through spinal
anesthesia, neurosurgery, or epidural steroid injections (Antinori
et al., 2013). Also, breach in the mucosal barrier, caused by
inflammation or proliferation of fungal elements in the sinus
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lumen has been cited as a precipitating factor, due to imbalance
in host-agent interactions and resulting in progression from
non-invasive to invasive disease (Rowe-Jones, 1993).
Although A. fumigatus is the leading cause of invasive
aspergillosis in immunocompromised individuals, A. terreus, A.
flavus, Aspergillus niger, and rarely Aspergillus nidulans have
been identified as etiological agents (Balajee, 2009). A. terreus is
an emerging opportunistic pathogen causing fatal disseminated
infections in immunocompromised populations with increasing
incidence from<2% in 1996 to 15% in 2001 (Baddley et al., 2003).
Resistances of A. terreus to amphotericin B, thermotolerance
and production of accessory conidia have been suggested as
mechanisms that explain rapid dissemination of the organism
during invasive infections (Blum et al., 2008).
The diagnosis of Aspergillus meningitis is challenging. In
fact, diagnosis during life was obtained in only 55.9% of
patients. Moreover, there is a reported higher frequency of
diagnosis during life among immunocompetent patients (69.2%)
as opposed to immunocompromised individuals (39%). This
difference might be explained by a more aggressive and acute
course of the disease in immunosuppressed hosts (Antinori et al.,
2013).
The overwhelming bulk of literature on aspergillosis is
concerned with immunocompromised hosts. Notable case
series of craniocerebral aspergillosis occurring in apparently
immunocompetent hosts have so far been reported mainly from
India, Sudan, Pakistan, Saudi Arabia, UAE, and a few other
African countries. On the contrary, reports from the West are
largely confined to isolated case reports. The reason for this
demographic difference is not clear, and a plausible explanation
may be the hot, dry climate, and low socioeconomic status in
the above-mentioned regions favor the growth of Aspergillus
(Shamim et al., 2007; Antinori et al., 2013). Antinori et al.
reviewed a number of Aspergillus meningitis cases and reported
that more than 50%were in individuals without any predisposing
factor or known immunosuppression (Antinori et al., 2013).
Also, Zhu et al. (2014) have reported that there was no decline
in immune function despit brain-occupying lesions caused by
Aspergillus infection.
The clinical presentation of patients with CNS aspergillosis
is variable and nonspecific (Pettit et al., 2012). Patients
typically present with fever, headaches, mental status changes, or
seizures. Some patients may show focal neurologic abnormality
such as hemiplegia and/or cranial nerve palsy or vision
changes (Kourkoumpetis et al., 2012). Usually, an acute course
characterized by rapid deterioration of the clinical picture usually
ending with death was observed among immunocompromised
hosts and in patients with direct inoculation of the fungus into
the cerebrospinal fluid or the subarachnoid space. By contrast,
a sub-acute or chronic form of meningitis was most frequent
among immunocompetent patients, intravenous drug abusers,
diabetic patients, and patients who had undergone neurosurgery
(Antinori et al., 2013).
CSF examination is often not very helpful in the diagnosis
of CNS aspergillosis, since confirmed cases might show negative
CSF culture (Kourkoumpetis et al., 2012; Antinori et al., 2013).
Isolation of Aspergillus from the cerebrospinal fluid is difficult
and often requires repeated testing of large volume samples.
Other CSF examination findings, such as cell count and protein
level, are also nonspecific (Kourkoumpetis et al., 2012).
In our case routine culture plates were negative and failed to
isolate Aspergillus. The isolation of Aspergillus only from CSF
put into blood culture bottles raised suspicion that it could
be a contaminant. Together the clinical course, CT scan of
head showing findings suggesting fungal sinusitis with “bilateral
sinupolyposis” and CSF studies (high protein, low glucose,
pleocytosis, negative gram stain) with no response to antibiotics,
raised the possibility of fungal meningitis. Also, there was a
potential source of exposure associated with sinus surgery. The
acute course of fungal meningitis with rapid deterioration in
immunocompetent patients is observed if direct inoculation of
the fungus into the cerebrospinal fluid or the subarachnoid space
occurs (Antinori et al., 2013). This prompted us to assume that
the patient had significant sinus-associated fungal disease before
surgery and that breach in mucosa or direct inoculation of the
fungus into the cerebrospinal fluid or the subarachnoid space had
occurred during intranasal surgery. The rapidly fatal course of
meningitis is consistent withA. terreus infection which has a high
rate of mortality due to its natural resistance to amphotericin B.
Allergic FRS is a common disorder in patients with sinonasal
polyposis. Due to its recurrent and intractable nature, a high
degree of clinical suspicion for the presence of FRS in nasal
polyposis should be considered (Jain et al., 2013). Although we
have no data on histopathology or culture of tissue excised during
surgery, the patient history of nasal polyposis together with CT
finding suggests the presence of allergic fungal sinusitis. This
condition is frequently treated by removing the allergic mucin
through surgical procedure. Breach in the mucosal barrier during
surgery can result in progression from non-invasive disease to
invasive form.
Although A. terreus is an unusual cause of CNS
invasion (Schwartz et al., 2007) and occurs mostly in
immunocompromised patients (Baddley et al., 2003), our
case was similar to a case reported by Akhaddar et al. (2008)
of invasive A. terreus sphenoidal sinusitis with intraorbital and
intracranial extension in an immunocompetent patient.
Antinori et al. (2013) has previously suggested that repeated
culture of large volumes of CSF (minimum 5ml) or serial lumbar
punctures should be done when mycosis is suspected. In this
case standard culturing practice for CSF was negative (incubation
period 48 h), while culturing in blood culture bottles was positive
after 3 days of incubation, meaning that a prolonged incubation
period was needed for the fungus to grow. Cetin et al. (2007) and
Udayan and Dias (2014) showed significant increase in isolation
rate for BACTEC culture over conventional culture methods
from normally sterile body fluids especially from cerebrospinal
and synovial fluid specimens. We suggest that culturing CSF
in blood culture bottles for more than 48 h should be done
if conventional culture is negative and fungal meningitis is
suspected.
The detection of aspergillus galactomannan in serum samples
by means of an enzyme immunoassay has been validated for
the diagnosis of invasive aspergillosis. This assay has also shown
promising results with cerebrospinal fluid specimens for the early
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diagnosis of CNS aspergillosis, although the threshold value for
the diagnosis has not been determined (Klont et al., 2004).
The widespread availability of neuroimaging (CT and MRI)
leading to earlier radiological diagnosis in these patients, and
thus earlier referrals to neurosurgical centers could also be
a contributing factor to the rising incidence of reports of
Aspergillus CNS infection. Although radiographic imaging may
be useful for identifying focal lesions or secondary complications,
aspergillus meningitis is usually characterized by an absence of
parenchymal lesions (Kourkoumpetis et al., 2012).
Aspergillosis in the CNS carries a poor prognosis, despite
the availability of antifungal agents with good activity against
aspergillus species and penetration into the CNS (Schwartz et al.,
2007). The overall case fatality rate was 72.1% in one report
(Kourkoumpetis et al., 2012). The case-fatality of patients with
CNS aspergillosis is the highest of all forms of aspergillosis;
with mortality as high as 100%. Mortality in patients treated
with voriconazole is still unacceptably high, and more effective
treatments are needed (Schwartz et al., 2007).
For patients who are intolerant to voriconazole due to
hepatotoxicity or other severe reactions, a lipid formulation of
amphotericin B (e.g., AmBisome or Abelcet) is a reasonable
alternative. The duration of antifungal therapy is dependent upon
the location of the infection, the patient’s underlying disease,
the need for further immunosuppression, and the response
to therapy. Antifungal therapy is generally continued until all
signs and symptoms of the infection have resolved (Marr et al.,
2015).
CONCLUSION
The rapid presentation after sinus surgery together with an acute
course of meningitis that culmoinated in rapid deterioration and
death in this immunocompetent patient was likely caused by
A. terreus meningitis. It seems likely that undiagnosed fungal
sinusitis was complicated by direct inoculation of the fungus into
the cerebrospinal fluid during sinus surgery. The rare clinical
occurrence of CNS aspergillosis necessitates presentation of case
series and case reports so that clinicians can assess the variable
presentations of this severe infection. Also, inoculating BACTEC
bottles as a means of cultureing CSF fungi needs to be looked into
further.
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